Grant: CIHR Fellowship
McGill University
$210,000.00
Effectiveness and safety of Wharton's Jelly mesenchymal stem cell for patients with xerostomia due to Sjogren's syndrome.
FY 2024-25
Summary
Sjögren's syndrome (SS) is a chronic, progressive condition predominantly affecting women, characterised by diminished production of bodily secretions. Insufficient saliva and its related symptoms, including xerostomia, compromised speech, dental caries, diminished taste perception, severe dysphagia, oral ulcerations, and infections, eventually result in a diminished quality of life. Xerostomia in SS is recognised to arise from dysregulation of the body's immunological processes. The existing therapy for xerostomia is palliative, focussing on alleviating the patient's symptoms temporarily. Symptomatic treatment with topical lubricants and immunosuppressive medications has demonstrated efficacy; nevertheless, these interventions are palliative and linked to several undesirable consequences. Furthermore, these medications do not repair or rehabilitate the glandular secretory activity. Notwithstanding scientific progress, a definitive and lasting therapy for xerostomia remains unestablished. Stem cells are specialised human cells capable of replacing cells that have been injured or destroyed due to illness. Recent advancements in stem cells and their use for treating dry mouth associated with oral cancer and SS have demonstrated significant potential. We suggest using stem cells specialised from the umbilical cord tissue to restore the salivary glands, hence enhancing salivary secretions. Dry mouth may also result from several health issues, including diabetes, stroke, oral fungal infections, Alzheimer's disease, and other autoimmune disorders, such as HIV/AIDS. The findings of our research may establish a novel technique for the creative application of stem cells in disorders that result in dry mouth, therefore addressing significant issues arising from diminished salivary secretions for millions of patients globally.
Department
Program
CIHR Fellowship
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
513876
Name
Iyer Janaki S
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Health Research Training B - HP
Projecttitle
Effectiveness and safety of Wharton's Jelly mesenchymal stem cell for patients with xerostomia due to Sjogren's syndrome.
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$210,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Dry Mouth; Mesenchymal Stem Cells; Salivary Gland Regeneration; Salivary Hypofunction; Sjogren'S Syndrome; Stem Cell Therapy; Umbilical Cord; Wharton'S Jelly; Xerostomia
Abstract
Sjögren's syndrome (SS) is a chronic, progressive condition predominantly affecting women, characterised by diminished production of bodily secretions. Insufficient saliva and its related symptoms, including xerostomia, compromised speech, dental caries, diminished taste perception, severe dysphagia, oral ulcerations, and infections, eventually result in a diminished quality of life. Xerostomia in SS is recognised to arise from dysregulation of the body's immunological processes. The existing therapy for xerostomia is palliative, focussing on alleviating the patient's symptoms temporarily. Symptomatic treatment with topical lubricants and immunosuppressive medications has demonstrated efficacy; nevertheless, these interventions are palliative and linked to several undesirable consequences. Furthermore, these medications do not repair or rehabilitate the glandular secretory activity. Notwithstanding scientific progress, a definitive and lasting therapy for xerostomia remains unestablished. Stem cells are specialised human cells capable of replacing cells that have been injured or destroyed due to illness. Recent advancements in stem cells and their use for treating dry mouth associated with oral cancer and SS have demonstrated significant potential. We suggest using stem cells specialised from the umbilical cord tissue to restore the salivary glands, hence enhancing salivary secretions. Dry mouth may also result from several health issues, including diabetes, stroke, oral fungal infections, Alzheimer's disease, and other autoimmune disorders, such as HIV/AIDS. The findings of our research may establish a novel technique for the creative application of stem cells in disorders that result in dry mouth, therefore addressing significant issues arising from diminished salivary secretions for millions of patients globally.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Iyer, Janaki S
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $210,000~ $0~